Cullinan Oncology, Inc. (CGEM) Stock Surges Following Positive Supplementary CLN-081 Study Information
Cullinan Oncology, Inc. (CGEM) stock prices were up by 18.63% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$35.30 early on in the trading day. CLN-081 Trial Update The oncology company announced supplementary information about Cullinan Pearl’s ongoing Phase 1/2a trial of CLN-081 on June 4th, 2021. […]
CoherusBioSciences, Inc. (CHRS) Stock on the Rise Following Success of JUPITER-02 Pivotal Study
CoherusBioSciences, Inc. (CHRS) stock prices were up by 3.53% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$13.50 early on in the trading day. JUPITER-02 Results The company recently announced the successful results from its pivotal study, JUPITER-02, which was a randomized, double-blind, placebo-controlled Phase 3 clinical […]
Berkeley Lights, Inc. (BLI) Stock Undergoes Minor Volatility as Development of Opto Assure Continues
Berkeley Lights, Inc. (BLI) stock prices were down by 3.18% as of the market closing on May 28th, 2021, bringing the price per share down to USD$43.50 at the end of the trading day. Revenue Reports and Growth in Bases The leader in Digital Cell Biology reported having generated USD$18.6 million in total revenue over […]
Eloxx Pharmaceuticals, Inc. (ELOX) Stock Trending Higher Following Funding Award from Cystic Fibrosis Foundation
Eloxx Pharmaceuticals, Inc. (ELOX) stock prices were up by 5.67% as of the market closing on May 27th, 2021, bringing the price per share up to USD$1.49 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 7.38%, bringing it up to USD$1.60. Acquisition of Zikani Therapeutics April 1st, […]
AIM ImmunoTech Inc. (AIM) Stock Undergoes Minor Volatility After Announcing Extension of Collaboration with Smoore
AIM ImmunoTech Inc. (AIM) stock prices were down by 1.42% as of the market closing on May 28th, 2021, bringing the price per share down to USD$2.08 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock fall by 2.40%, bringing it down to USD$2.03. Extension of Agreement with Smoore May […]
Lannett Company, Inc. (LCI) Stock Trending Higher Following Development of its Product Pipeline
Lannett Company, Inc. (LCI) stock prices were up by 4.66% a of the market closing on May 27th, 2021, bringing the price per share up to USD$4.94. Refinancing Debt Recent months have seen LCI substantially advance various strategic initiatives, including the company’s successful completion of a transaction in April to refinance their debt. The capital […]
Syros Pharmaceuticals, Inc. (SYRS) Stock on the Rise following Promising Financial Reports for Q1 2021
Syros Pharmaceuticals, Inc. (SYRS) stock prices were up by 17.98% shortly after market trading commenced, bringing the price per share up to USD$6.60 early in the trading day. Revenue Breakdown Revenues for the first quarter of the fiscal year 2021 were reported at USD$4.8 million of which USD$4 million in revenue being recognized under the […]
Purple Biotech Ltd. (PPBT) Stock Undergoes Minor Volatility Amid Progression of CM24 Clinical Trial
Purple Biotech Ltd. (PPBT) stock prices were up by 2.15% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.76 at the end of the trading day. Subsequent pre-market fluctuations saw the price dip by a marginal 1.05%, bringing it down to USD$4.71. CM24 Trial Commences Patient Dosing […]
Tenax Therapeutics, Inc. (TENX) Stock Undergo Minor Volatility Following Further Development of its Pipeline Candidates
Tenax Therapeutics, Inc. (TENX) stock prices were down by a marginal 0.53% as of the market closing on May 25th, 2021, bringing the price per share down to USD$1.88 at the end of the trading day. R&D Expenses Expenses incurred by research and development during the first quarter of the fiscal year 2021 came out […]
Taiwan Liposome Company, Ltd. (TLC) Stock Soars After Indian Approval for AmphoTLC
Taiwan Liposome Company, Ltd. (TLC) stock prices were up by 34.95% shortly after the market opened on May 25th, 2021, bringing the price per share up to USD$6.68 shortly after the trading day commenced. Indian Approval for AmphoTLC TLC announced on May 25th, 2021 that the Central Drugs Standard Control Organization (CDSCO) of India had […]
Myovant Sciences Ltd. (MYOV) Stock Continues Uptrend Following Pipeline Candidate Development
Myovant Sciences Ltd. (MYOV) stock prices were up by 3.33% as of the market closing on May 21st, 2021, bringing the price per share up to USD$22.98 at the end of the trading day. Launch of ORGVYX ORGOVYX saw its launch in the United States commencing in early January of the fiscal year 2021, with […]
Annovis Bio, Inc. (ANVS) Stock Skyrockets Following Success of Clinical Trial and Subsequent Public Offering
Annovis Bio, Inc. (ANVS) stock prices skyrocketed by a staggering 127.27% as of the market closing on May 21st, 2021, bringing the price per share up to an even USD$60.00. ANVS401 Study The company announced on May 21st, 2021 the success of its double-blind placebo-controlled study in the treatment of Alzheimer’s Disease. Patients treated with […]
Intec Pharma Ltd. (NTEC) Stock Trending Higher Following Progress on Merger with Decoy Biosystem
Intec Pharma Ltd. (NTEC) stock prices were up by 3.02% as of the market closing on May 20th, 2021, bringing the price per share up to USD$3.75 at the end of the trading day. Merger with Decoy Announced March 15th, 2021 saw NTEC announce that it had entered into a definitive agreement with Decoy Biosystems. […]
PolarityTE, Inc. (PTE) Stock Trending Down Shortly After Disclosure of Promising Q1 2021 Financials
PolarityTE, Inc. (PTE) stock prices were down by 6.62% as of the market closing on May 17th, 2021, bringing the price per share down to USD$0.912 at the end of the trading day. Promising Trajectory The company consolidated its prior guidance in the first quarter of the fiscal year 2021 in regard to the submission […]
Oragenics, Inc. (OGEN) Stock Undergoes Volatility Following Changes in Management and Board of Directors
Oragenics, Inc. (OGEN) stock prices were up by 3.32% as of the market closing on April 14th, 2021, bringing the price per share up to USD$0.6199 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock jump by 1.64%, bringing it up to USD$0.62. Net Loss Reports March 3rd, 2021 saw […]
Orphazyme A/S (ORPH) Stock Plummeting After Failure of ORAIALS-01 Trial Announced
Orphazyme A/S (ORPH) stock prices plummeted by 27.77% after the market opened on May 7th, 2021, bringing the price per share tumbling down to USD$6.12 after the commencing of the trading day. ORAIALS-01 Ends in Failure The company announced on May 7th, 2021 that the ORAIALS-01 pivotal trial of arimoclomol in amyotrophic lateral sclerosis (ALS) […]
Epizyme, Inc. (EPZM) Stock Experiences Volatility Following Disclosure of Q1 2021 Financial Reports
Epizyme, Inc. (EPZM) stock prices were down by 9.44% as of the market closing on May 6th 2021, bringing the price per share down to USD$6.81 at the end of the trading day. Subsequent current-market fluctuations have seen the stock rally by 20%, bringing it up to USD$8.17. Financial Reports Indicate Strong Growth The first […]
Amgen, Inc. (AMGN) Stock Prices Undergo Volatility as Global Pandemic on Verge of Easing Up
Amgen, Inc. (AMGN) stock prices were down a marginal 0.15% as of market close on April 27th, 2021, inching the price down to USD$255.13. Subsequent pre-market fluctuations saw the stock price fall by 3.38%, bringing the price per share down to USD$246.50. Total Revenues Suffer The COVID-19 pandemic has been devastating for Amgen since its […]
Vaxart, Inc. (VXRT) Stock Prices Skyrocket Following Announcement of T-cell Webinar
Vaxart, Inc. (VXRT) stock prices were up a staggering 37.46% as of market close on April 27th, 2021, bringing the price per share up to USD$8.33. Novel COVID-19 Tablet With the world hurtling towards COVID-19 solutions for the pandemic, VXRT is setting itself apart from its competitors with a drug, VXA-CoV2-1, that comes in tablet […]
Cassava Sciences, Inc. (SAVA) Stock Prices on the Rise After Success of Clinical Trials
Cassava Sciences, Inc. (SAVA) stock prices were up 5.61% as of market close on April 26th 2021, bringing the price per share up to USD$41.81 at the end of the trading day. Subsequent current market fluctuations saw the stock price climb 3.78% to it USD$43.39. SAVA’s Net Loss In their recently disclosed financial reports for […]
Teligent, Inc. (TLGT) Stock Prices Trend Up as Company Consolidates its Financials and Hires New Senior Management
Teligent, Inc. (TLGT) stock prices were up 3.69% as of market close on April 26th, 2021, bringing the price per share up to USD$0.6010. Subsequent pre-market fluctuations saw the stock surge 12.31%, bumping it up to USD$0.68. Conversion of Outstanding Debt January 27th, 2021 saw the company’s Series C noteholders exchange the entirety of their […]